While fallopian tube cancer is rare, Penn Medicine sees a high volume of people in the region who need fallopian tube cancer care. Fallopian tube cancer is similar to ovarian cancer, and often treated in the same way, so that people with this type of cancer benefit from our nationally recognized ovarian cancer care.
Penn is on the Forefront of Gynecologic Cancer Research
Penn researchers discovered that ovarian cancers can originate in the fallopian tubes. Our deeply researched fallopian tube cancer care involves genetic testing for each tumor, to determine personalized, precision care for each patient.
Our Fallopian Tube Cancer Care is Collaborative
We have more full-time, board-certified gynecologic oncologists than any other hospital in the Philadelphia region. Our entire team, including medical oncologists, pathologists, surgeons and radiation specialists, meets weekly to discuss joint treatment plans that are unique to each patient. Because cancer and its treatment can affect the whole body, we partner closely with specialists throughout Penn Medicine. This collaborative model lets us take on a greater complexity of care.
We Treat a High Number of Gynecologic Cancers Each Year
The Abramson Cancer Center is a high-volume cancer center, meaning that we treat a large number of people with cancer. Studies show that treatment at a high-volume cancer center increases the odds of survival.
Multiple Fallopian Tube Clinical Trials are Available
We encourage patients to enroll in one of our innovative clinical trials, such as immunotherapy that trains the body to fight cancer from within. Clinical trials can be used as a single treatment or combined with traditional treatments, such as chemotherapy. Some of these treatments, such as CAR-T immunotherapy, are only available at Penn.